• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchKazia Therapeutics
    Picture of Kazia Therapeutics logo

    KZIA — Kazia Therapeutics Share News

    $8.070.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    • Market Cap
      $0.07m
    • Enterprise Value
      -$38.66m
    • Revenue
      AU$0.11m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • KZIA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    KZIA Dividends
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE

      18/10/2018 08:58
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE

      17/10/2018 08:58
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE

      16/10/2018 08:58
    • NASDAQ TRADE HALT HALT REGULATORY CONCERN

      15/10/2018 11:40
    • Brief: Novogen says patent covering Cantrixil and Trilexium has been granted in Australia

      19/02/2016 05:14
    • Brief: Novogen patent covering cantrixil, trilexium accepted in Australia

      12/11/2015 12:03
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.